Shedding light on medical cannabis

A number of EU countries are developing or have already put in place policies for granting patients easier access to medical marijuana after Germany led the way by passing a reform of the country's drugs law in 2017. [SHUTTERSTOCK]

The medical cannabis industry is growing rapidly in Europe and thousands of patients are already prescribed with cannabis-based drugs. This created a new demand that now runs the risk of being unsatisfied if the legislation remains fragmented amongst EU countries.

Several decision-makers and stakeholders are calling on the European Commission to investigate which kind of regulatory measures at the EU level should be put in place to meet patients’ needs.

Standards, safety, ethics and sustainability are the topics to discuss further when it will be time to draft guidelines and pieces of regulation with the aim of creating a regulatory environment for patients and investors.

Download PDF  

Subscribe to our newsletters